Feed ORKA
OR
Oruka Therapeutics, Inc.
ORKA · NASDAQ
$112.66 +1.04% (+$1.16)
1M +22.84%
Market Cap $6.8B
P/E Ratio -
Div. Yield -
ROE 25.99%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 13.96x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 27.31%
ROE 25.99%
ROA 23.04%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 23.76x
Int. coverage N/A
Stability
50 /100
Moderate Beta -0.39x
Rev. volatility N/A
EPS volatility N/A
Ask StockBot about ORKA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lawrence Otto Klein
Employees
68
Headquarters
Menlo Park
Upcoming events
11 NOV
Earnings
Upcoming earnings report